Understanding potential overlapping side effects, monitoring requirements, and UK regulatory guidance is essential
Brain health and dementia risk: promising but evolving Large observational studies have associated GLP-1 use with a lower risk of Alzheimers disease compared to some other diabetes treatments (Xie et al., 2023)
Because we offer both Semaglutide and Tirzepatide, our team can personalize your plan and adjust it as your body responds
For more details, see the articles on Gut Influences and Targeting the Gut
A: The semaglutide dosage for weight loss typically starts at 0.25 mg and gradually increases
Therapeutic response is dose- and time-dependent: The maximal improvements in aminotransferases and liver fat content typically occur around 28 to 30 weeks after initiating therapy, indicating that sustained treatment is necessary to achieve optimal benefit